Financials data is unavailable for this security.
View more
Income statement information is not available for Argent Biopharma Ltd .
Gross margin | 21.87% |
---|---|
Net profit margin | -1,295.20% |
Operating margin | -1,175.76% |
Return on assets | -105.32% |
---|---|
Return on equity | -- |
Return on investment | -345.98% |
More ▼
Cash flow in AUDView more
In 2024, Argent Biopharma Ltd increased its cash reserves by 193.08%, or 463.05k. Cash Flow from Financing totalled 14.87m or 1,668.25% of revenues. In addition the company used 14.26m for operations while cash used for investing totalled 140.12k.
Cash flow per share | -1.21 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0372 |
---|---|
Tangible book value per share | 0.0372 |
More ▼
Balance sheet in AUDView more
Current ratio | 0.7551 |
---|---|
Quick ratio | 0.6561 |
Total debt/total equity | 0.3449 |
---|---|
Total debt/total capital | 0.4104 |
More ▼